MTRG researchers regularly publish journal articles and policy reports on issues related to medical technology policy, regulation and assessment.

Publications 

• Kamphuis, B. W. & Kanavos, P. (2021) Assessing pricing and reimbursement policies for generic pharmaceuticals in the MENA region for improved efficiency, affordability and generic penetration, Health Policy OPEN 2, 100045

• Angelis, A., Kanavos. P, Philips L.D. (2020) ICER Value Framework 2020 Update: recommendations on the aggregation of benefits and contextual considerations, Value in Health 23 (8), 1040-1048
• Kanavos P., Fontrier A-M., Gill J., Efthymiadou O.(2020) Does external reference pricing deliver what it promises? Evidence on its impact at national level. Eur J Health Econ 21, 129–151
• Kanavos P., Kamphuis B.W., Fontrier A-M., Colville Parkin G., Saleh S., Ahkras, K.S.(2020) Assessing External Reference Pricing (ERP) systems for in-patent pharmaceuticals in eleven MENA countries for compatibility with best practice principles for ERP, Health Policy. Volume 124, Issue 12, 1297-1309
• Miracolo A., Sophiea M., Mills M., Kanavos P. (2020) The impact of sin taxes on consumption, revenue generation and health improvement: A systematic literature review in Latin America, Health Policy and Planning, Oxford University Press

Policy reports

• Kamphuis, B.W., Fontrier, A-M., Haig, M., Politopoulou, K., Salyga, H., Gentilini, A., and Kanavos, P. (2022). Development of policies to increase headroom for innovation in Egypt and the Kingdom of Saudi Arabia, The London School of Economics and Political Science, London, UK.
• Kamphuis, B.W., Fontrier, A-M., Efthymiadou, O., Gill, J., Salyga, H., and Kanavos, P. (2021) Access to medicines in Europe: Delays and challenges for timely patient access, The London School of Economics and Political Science, London, UK.  
• Kamphuis, B.W., Gill, J., Vogelzang, M., Haig, M. and Kanavos, P. (2021) The Role of Virtual Health Care and the Pharmaceutical Sector in Improving Population Health, The London School of Economics and Political Science, London, UK.  
• Kamphuis B.W., Efthymiadou, O., Tzouma, V. & Kanavos, P. (2021) Severe asthma care and treatment: Indicators and data for performance management across ten countries, The London School of Economics and Political Science, London, UK.
• Efthymiadou, O., Kamphuis B.W., Tzouma, V. & Kanavos, P. (2021) Treatment gaps in severe asthma across nine OECD countries and recommendations for addressing them: An international survey of clinicians, The London School of Economics and Political Science, London, UK.
• (2021) MSD Global Oncology Policy 2019 Grants Program: Report of the Inaugural Forum, The London School of Economics and Political Science, London, UK.
• Gill JL., Fontrier A-M., Miracolo A. & Kanavos P. (2020) Access to Personalised Oncology in Europe, The London School of Economics and Political Science, London, UK.
  
• Kanavos P., Colville Parkin G., Kamphuis B.W. & Gill J. (2019) Latin America Healthcare System Overview: A comparative analysis of fiscal space in healthcare, The London School of Economics and Political Science, London, UK.
• Gill J. et al. (2018) Paper IV: Engaging Pharma in the RWE Roadmap, The London School of Economics and Political Science, London, UK.
• Kamphuis B.W. et al. (2018) Paper V: Policy Challenges around Real World Evidence Adoption in Europe, The London School of Economics and Political Science, London, UK.
• Kanavos P., Tzouma V., Fontrier A-M., Kamphuis B.W., Colville Parkin G., Saleh S. (2018) Pharmaceutical Pricing and Reimbursement in the Middle East and North Africa Region: A Mapping of the Current Landscape and Options for the Future, The London School of Economics and Political Science, London, UK.
• Kanavos P, Tzouma V, Efthymiadou O, Mills M, Flannelly C. (2018) Accelerated Approval and Access Schemes: A mapping of policies across the globe and the impact of accelerated approval on the HTA of new oncology medicines, The London School of Economics and Political Science, London, UK.